Zhongzhu End Period Cash Flow from 2010 to 2024

600568 Stock   1.57  0.01  0.64%   
Zhongzhu Medical's End Period Cash Flow is decreasing over the years with slightly volatile fluctuation. Overall, End Period Cash Flow is expected to go to about 654.9 M this year. From 2010 to 2024 Zhongzhu Medical End Period Cash Flow quarterly data regression line had arithmetic mean of  1,145,180,210 and r-squared of  0.75. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-09-30
Previous Quarter
291.6 M
Current Value
297.2 M
Quarterly Volatility
126.6 M
 
Covid
Check Zhongzhu Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhongzhu Medical's main balance sheet or income statement drivers, such as Interest Expense of 7.8 M, Selling General Administrative of 86.5 M or Total Revenue of 901.1 M, as well as many indicators such as . Zhongzhu financial statements analysis is a perfect complement when working with Zhongzhu Medical Valuation or Volatility modules.
  
This module can also supplement various Zhongzhu Medical Technical models . Check out the analysis of Zhongzhu Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Zhongzhu Stock

Zhongzhu Medical financial ratios help investors to determine whether Zhongzhu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhongzhu with respect to the benefits of owning Zhongzhu Medical security.